Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
Saved in:
| Title: | Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives. |
|---|---|
| Authors: | Asphaug L; Clinical Trials Unit, Oslo University Hospital, Oslo, Norway; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. Electronic address: larasp@ous-hf.no., Akslen LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, Norway; Department of Pathology Haukeland University Hospital, Bergen, Norway., Blix ES; Department of Oncology, University of North Norway, Tromsø, Norway; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Boge B; Department of Oncology, Hospital of Southern Norway, Kristiansand, Norway., Borgen EF; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Brekke MB; Department of Pathology, St Olavs Hospital, Trondheim, Norway., Falk RS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Geitvik GA; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Gilje B; Department of Haematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Gravdehaug B; Department of Breast Surgery, Akershus University Hospital, Lørenskog, Norway., Heie A; Department of Breast Surgery, Haukeland University Hospital, Bergen, Norway., Janssen E; Department of Pathology, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway; Menzies Health Institute Queensland and Griffith University, Southport, Australia., Kiserud CE; National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Kursetgjerde T; Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund, Norway., Langerød A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lømo J; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Mannsåker B; Department of Oncology, Nordland Hospital, Bodø, Norway., Mortensen E; Department of Pathology, University of North Norway, Tromsø, Norway., Olsson P; Department of Breast Surgery, Innlandet Hospital Trust, Hamar, Norway., Porojnicu AC; Department of Oncology, Vestre Viken Hospital Trust, Drammen, Norway., Raj SX; Department of Oncology, St Olavs Hospital, Trondheim, Norway., Roe OD; Department of Oncology, Levanger Hospital, Levanger, Norway., Russnes HEG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Skjerven HK; Department of Breast Surgery, Vestre Viken Hospital Trust, Drammen, Norway., Songe-Møller S; Department of Oncology, Østfold Hospital Trust, Kalnes, Norway., Vestlid MA; Department of Breast Surgery, Telemark Hospital Trust, Skien, Norway., Ohnstad HO; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Naume B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2025 Aug; Vol. 25 (6), pp. e721-e730. Date of Electronic Publication: 2025 Apr 15. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40348620 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Asphaug+L%22">Asphaug L</searchLink>; Clinical Trials Unit, Oslo University Hospital, Oslo, Norway; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. Electronic address: larasp@ous-hf.no.<br /><searchLink fieldCode="AU" term="%22Akslen+LA%22">Akslen LA</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, Norway; Department of Pathology Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Blix+ES%22">Blix ES</searchLink>; Department of Oncology, University of North Norway, Tromsø, Norway; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Boge+B%22">Boge B</searchLink>; Department of Oncology, Hospital of Southern Norway, Kristiansand, Norway.<br /><searchLink fieldCode="AU" term="%22Borgen+EF%22">Borgen EF</searchLink>; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Brekke+MB%22">Brekke MB</searchLink>; Department of Pathology, St Olavs Hospital, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Falk+RS%22">Falk RS</searchLink>; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Geitvik+GA%22">Geitvik GA</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gilje+B%22">Gilje B</searchLink>; Department of Haematology and Oncology, Stavanger University Hospital, Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Gravdehaug+B%22">Gravdehaug B</searchLink>; Department of Breast Surgery, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Heie+A%22">Heie A</searchLink>; Department of Breast Surgery, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Janssen+E%22">Janssen E</searchLink>; Department of Pathology, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway; Menzies Health Institute Queensland and Griffith University, Southport, Australia.<br /><searchLink fieldCode="AU" term="%22Kiserud+CE%22">Kiserud CE</searchLink>; National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kursetgjerde+T%22">Kursetgjerde T</searchLink>; Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund, Norway.<br /><searchLink fieldCode="AU" term="%22Langerød+A%22">Langerød A</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lømo+J%22">Lømo J</searchLink>; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Mannsåker+B%22">Mannsåker B</searchLink>; Department of Oncology, Nordland Hospital, Bodø, Norway.<br /><searchLink fieldCode="AU" term="%22Mortensen+E%22">Mortensen E</searchLink>; Department of Pathology, University of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Olsson+P%22">Olsson P</searchLink>; Department of Breast Surgery, Innlandet Hospital Trust, Hamar, Norway.<br /><searchLink fieldCode="AU" term="%22Porojnicu+AC%22">Porojnicu AC</searchLink>; Department of Oncology, Vestre Viken Hospital Trust, Drammen, Norway.<br /><searchLink fieldCode="AU" term="%22Raj+SX%22">Raj SX</searchLink>; Department of Oncology, St Olavs Hospital, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Roe+OD%22">Roe OD</searchLink>; Department of Oncology, Levanger Hospital, Levanger, Norway.<br /><searchLink fieldCode="AU" term="%22Russnes+HEG%22">Russnes HEG</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Skjerven+HK%22">Skjerven HK</searchLink>; Department of Breast Surgery, Vestre Viken Hospital Trust, Drammen, Norway.<br /><searchLink fieldCode="AU" term="%22Songe-Møller+S%22">Songe-Møller S</searchLink>; Department of Oncology, Østfold Hospital Trust, Kalnes, Norway.<br /><searchLink fieldCode="AU" term="%22Vestlid+MA%22">Vestlid MA</searchLink>; Department of Breast Surgery, Telemark Hospital Trust, Skien, Norway.<br /><searchLink fieldCode="AU" term="%22Ohnstad+HO%22">Ohnstad HO</searchLink>; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Naume+B%22">Naume B</searchLink>; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2025 Aug; Vol. 25 (6), pp. e721-e730. <i>Date of Electronic Publication: </i>2025 Apr 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40348620 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clbc.2025.04.011 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e721 Titles: – TitleFull: Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Asphaug L – PersonEntity: Name: NameFull: Akslen LA – PersonEntity: Name: NameFull: Blix ES – PersonEntity: Name: NameFull: Boge B – PersonEntity: Name: NameFull: Borgen EF – PersonEntity: Name: NameFull: Brekke MB – PersonEntity: Name: NameFull: Falk RS – PersonEntity: Name: NameFull: Geitvik GA – PersonEntity: Name: NameFull: Gilje B – PersonEntity: Name: NameFull: Gravdehaug B – PersonEntity: Name: NameFull: Heie A – PersonEntity: Name: NameFull: Janssen E – PersonEntity: Name: NameFull: Kiserud CE – PersonEntity: Name: NameFull: Kursetgjerde T – PersonEntity: Name: NameFull: Langerød A – PersonEntity: Name: NameFull: Lømo J – PersonEntity: Name: NameFull: Mannsåker B – PersonEntity: Name: NameFull: Mortensen E – PersonEntity: Name: NameFull: Olsson P – PersonEntity: Name: NameFull: Porojnicu AC – PersonEntity: Name: NameFull: Raj SX – PersonEntity: Name: NameFull: Roe OD – PersonEntity: Name: NameFull: Russnes HEG – PersonEntity: Name: NameFull: Skjerven HK – PersonEntity: Name: NameFull: Songe-Møller S – PersonEntity: Name: NameFull: Vestlid MA – PersonEntity: Name: NameFull: Ohnstad HO – PersonEntity: Name: NameFull: Naume B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1938-0666 Numbering: – Type: volume Value: 25 – Type: issue Value: 6 Titles: – TitleFull: Clinical breast cancer Type: main |
| ResultId | 1 |